Mission Optimization Sample Clauses

Mission Optimization. Sea Launch shall optimize, within the constraints of the LV, the mission design consistent with Paragraphs 2.2.1 above. The orbital parameters shall be optimized for the final design mass (defined in Table 7-1, Item 3) and operational characteristics of the SC (defined in Table 7-1, Items 4 and 36). Performance curves of the Launch Vehicle shall be provided to Inmarsat to support this optimization. For each month for the 12 consecutive months, Sea Launch will design a launch vehicle ascent trajectory that meets the customer’s orbital requirements. The Zenit-2S portion of flight (first two stages) will at a maximum have two trajectories, one for a northern launch azimuth and one for a southern launch azimuth. The Block XX-XX portion of flight (third stage) will be unique for each month in order to satifsy the argument of perigee requirement. Vehicle flight task development will begin at L-5 months. Depending on the results of prior analyses, work will begin on one or two Zenit-2S flight tasks plus three or four Block XX-XX flight tasks. These flight tasks will cover the launch slot plus subsequent months in order to ensure that all flight tasks will be ready in the case of a launch delay. As the launch slot narrows or shifts, work on flight tasks that no longer apply will be terminated, and possibly work on new flight tasks will begin. Such modifications will be coordinated with the customer. The maximum number of mission designs will be 12. The number of Block XX-XX flight tasks is anticipated to be smaller, although that number could also be 12 if delays in launch occurred right before the SC is supposed to arrive at Home Port. Only 1 or 2 Zenit-2S flight tasks would be required. If the launch were to slide outside the contractual launch period and the contract were extended, Sea Launch will continue to produce additional mission designs and flight tasks as necessary to protect the launch date.
Sample 1Sample 2
AutoNDA by SimpleDocs
Mission Optimization. Sea Launch shall optimize the mission design consistent with the constraints of the LV and Paragraph 2.2.1 above. The orbital parameters shall be optimized for [***]. Performance curves of the Launch Vehicle shall be provided to XM and BSS to support this optimization.
Sample 1
Mission Optimization. Launch Provider shall optimize the mission design consistent with the constraints of the LV, Paragraph 2.2.1 above, and the requirements of the Customer. The Customer shall provide the target specification/Launch windows that take into consideration all Spacecraft post-separation mission requirements, constraints and orbital perturbations. The orbital parameters shall be optimized for the [*]. Performance curves of the Launch Vehicle shall be provided to Customer to support this optimization.
Sample 1

Related to Mission Optimization

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Project Description The Project Description may be changed from time to time by, or with the consent of, the Company provided that any such change shall also be filed with the Issuer and provided further that no change in the Project Description shall materially change the function of the Project Facilities unless the Trustee shall have received (i) an Engineer's certificate that such changes will not impair the significance or character of the Project Facilities as Pollution Control Facilities and (ii) an Opinion of Bond Counsel or ruling of the Internal Revenue Service to the effect that such amendment will not adversely affect the exclusion of interest on the Bonds from gross income for federal income tax purposes.

  • Project Plan Based on the Project Specifications, Omnicare CR has provided a description of services to be performed for Sponsor’s “A multi-center, randomized, double-blind, double-dummy, vehicle-controlled sequential cohort study to determine the safety of PEP005 0.025% and 0.05% topical gel in patients with actinic keratoses” (hereinafter “the Project”) and associated costs. Changes made in the Project scope, at any time during the Project, will result in a corresponding adjustment to the Project costs.

  • Mission Payload The payload for a stage length of [*] nautical miles in still air (equivalent to a distance of [*] nautical miles with a [*] wind, representative of a [*] route in [*]) using the conditions and operating rules defined below, shall not be less than the following guarantee value: NOMINAL: [*]0 Kilograms TOLERANCE: [*] Kilograms GUARANTEE: [*] Kilograms

  • Scope of Work The Service Provider is to provide the Customer with the following services (the “Services”): Company Administration. The services will include any other tasks which the Customer and the Service Provider may agree on.

  • Engineering Services The Borrower’s Engineer will provide engineering services covering planning and design, operation of the System, and the supervision and inspection of the construction of the Project. The Borrower’s Engineer will provide to the Department the certificate required by Section 3.4.

  • Timeline a. Year 1: 20[***] (spring) plant SG and evaluate herbicides. CERES-NOBLE Schedule BMP for switchgrass Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission

  • Deliverables Upon completion of each Test for each Reviewable Receivable, the Asset Representations Reviewer shall record a finding based on the issues discovered. Findings categories are listed as follows: • Evidence that the applicable Test was satisfied (“Satisfied Test”); • Evidence that the applicable Test was not satisfied (“Unsatisfied Test”); and • Test incomplete as a result of missing or insufficient documentation (“Unsatisfied Test – Missing Required Documents”).

  • Development Milestones Subject to the terms and conditions of this Agreement, no later than [**] following the first occurrence of each event described below (each, a “Development Milestone”), on Product-by-Product basis Moderna shall pay Carisma the non-refundable and non-creditable amounts set forth below for each Product to achieve such event (each, a “Development Milestone Payment”): ​ Development MilestoneDevelopment Milestone Payment (in US$ millions) [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] ​ Moderna shall provide written notice to Carisma of the achievement of each Development Milestone within [**] after such achievement. If a Development Milestone for a Product is achieved without the preceding Development Milestone(s) having been achieved for such Product, then the Development Milestone Payment for such preceding Development Milestone(s) shall be paid by Moderna to Carisma together with ​ ​ the Development Milestone Payment for the Development Milestone that was achieved. For example, if the [**] Development Milestone [**] in the table above is achieved for a Product but the [**] Development Milestone [**] in the table above had not been achieved for such Product, then Moderna would pay the Development Milestone Payment for both such [**] Development Milestone and [**] Development Milestone upon achievement of the [**] Development Milestone. Each of the Development Milestone Payments set forth above shall be payable one time only per Product. If Moderna or its Affiliates or Sublicensees Develops a Product that has achieved at least one Development Milestone and subsequently discontinues Development of such Product and Develops a different Product incorporating or directed to the same combination of Collaboration Targets (whether one Collaboration Target or multiple Collaboration Targets), then Moderna shall be required to pay Development Milestone Payments for such different Product only for Development Milestones that had not been achieved by such discontinued Product.

  • Acceptance Testing The MCP must have the capability to report all elements in the Minimum Data Set as set forth in the ODJFS Encounter Data Specifications and must submit a test file in the ODJFS-specified medium in the required formats prior to contracting or prior to an information systems replacement or update. Acceptance testing of encounter data is required as specified in Section 29(a)(v) of this Appendix.

Time is Money Join Law Insider Premium to draft better contracts faster.